PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - 8-K Filing
Pacific Biosciences reports Q3 2026 revenue of $40.6 million and announces CFO transition. (Items: 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION, 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFI, 9.01 FINANCIAL STATEMENTS AND EXHIBITS)
Tickers: $PACB